A $100 million investment in a single round? That’s not usual for the Indian health-tech space.
However, Mumbai based e-pharmacy PharmEasy is apparently in talks with multiple investors for that exact figure.
PharmEasy has stayed mum about investments, but an investment banker says that it’s the frontrunner among Indian e-pharmacies for the coveted $100 million. The investment banker is one among many trying to figure out a way to broker an investment deal between large multinational investors—namely SoftBank, Naspers and Temasek—and PharmEasy.